Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

IMNN Relative to the S&P 500

IMNN Relative to the Sector

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Imunon, Inc. (NASD:IMNN) seasonal charts above shows that a Buy Date of February 15 and a Sell Date of June 5 has resulted in a geometric average return of 7.57% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 12 of those periods. This is a fair rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 107.57% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Imunon Inc is developing new medicines that harness the building blocks of life to work in harmony with the body’s immune system. It is a fully integrated, clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body’s natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases.

To download IMNN seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: IMNN